T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemia.
Alachkar H, Mutonga M, Malnassy G, Park JH, Fulton N, Woods A, Meng L, Kline J, Raca G, Odenike O, Takamatsu N, Miyamoto T, Matsuo Y, Stock W, Nakamura Y.
Alachkar H, et al. Among authors: meng l.
Oncotarget. 2015 Oct 20;6(32):33410-25. doi: 10.18632/oncotarget.5418.
Oncotarget. 2015.
PMID: 26450903
Free PMC article.